诺瓦瓦克斯医药 | 6.68 +0.15 +2.30% | ||
| NVAX | |||
| 高 6.72 | 开 6.60 | 量 393.35万股 | 总市值 10.85亿 |
| 低 6.55 | 换 2.42% | 额 2617.03万 | 市盈TTM 3.18 |
分时
5日
日K
周K
月K
季K
年K
诺瓦瓦克斯医药(NVAX)
12-16 06:26
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-121103 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
11-14 06:25
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-111494 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
11-13 05:25
$诺瓦瓦克斯医药(NVAX)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001398344-25-020786 Act: 34 Size: 31 KB 网页链接
诺瓦瓦克斯医药(NVAX)
11-06 21:05
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001000694-25-000048 Act: 34 Size: 323 KB 网页链接
诺瓦瓦克斯医药(NVAX)
11-06 20:55
$诺瓦瓦克斯医药(NVAX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001000694-25-000046 Act: 34 Size: 9 MB 网页链接
诺瓦瓦克斯医药(NVAX)
11-04 19:15
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-105818 Act: 34 Size: 225 KB 网页链接
诺瓦瓦克斯医药(NVAX)
10-31 04:35
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-104413 Size: 7 KB 网页链接
诺瓦瓦克斯医药(NVAX)
10-22 19:05
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 1.01, 2.06, 8.01, and 9.01 Accession Number: 0001104659-25-101390 Act: 34 Size: 257 KB 网页链接
诺瓦瓦克斯医药(NVAX)
10-14 19:55
$诺瓦瓦克斯医药(NVAX)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001398344-25-019099 Act: 34 Size: 146 KB 网页链接
诺瓦瓦克斯医药(NVAX)
10-07 19:05
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-097317 Act: 34 Size: 236 KB 网页链接
诺瓦瓦克斯医药(NVAX)
08-28 04:45
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-084049 Act: 34 Size: 232 KB 网页链接
诺瓦瓦克斯医药(NVAX)
08-28 04:45
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 1.01, 2.03, 3.02, and 9.01 Accession Number: 0001104659-25-084053 Act: 34 Size: 1 MB 网页链接
诺瓦瓦克斯医药(NVAX)
08-21 19:55
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001104659-25-081160 Act: 34 Size: 379 KB 网页链接
诺瓦瓦克斯医药(NVAX)
08-06 20:05
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001000694-25-000031 Act: 34 Size: 311 KB 网页链接
诺瓦瓦克斯医药(NVAX)
08-06 19:55
$诺瓦瓦克斯医药(NVAX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001000694-25-000029 Act: 34 Size: 10 MB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062192 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062191 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062193 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062195 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062196 Size: 8 KB 网页链接